Line 17: | Line 17: | ||
A biobrick coding FRB with mutation T2098L was already in the parts registry (iGEM Part_ J18926) but it was not available. Moreover it contains only one mutation on the 3 described in the literature. So we decided to work with the fully mutant FRB. Rapalog and plasmid with mutant FRB and FKBP12 were offered to us by Takara Clontech. But like we mentioned previously this system is used in mammal cells, so we decide to optimize the sequences for an expression in E.coli with the Jcat plateforme. So we finally order GBlock of our optimized sequences and a linker in prevision to the fusion with their respective dCas9.<br><br> | A biobrick coding FRB with mutation T2098L was already in the parts registry (iGEM Part_ J18926) but it was not available. Moreover it contains only one mutation on the 3 described in the literature. So we decided to work with the fully mutant FRB. Rapalog and plasmid with mutant FRB and FKBP12 were offered to us by Takara Clontech. But like we mentioned previously this system is used in mammal cells, so we decide to optimize the sequences for an expression in E.coli with the Jcat plateforme. So we finally order GBlock of our optimized sequences and a linker in prevision to the fusion with their respective dCas9.<br><br> | ||
Using these two systems (dCas9 recognition and FRB/FKBP12 dimerization) we design our new tool based on the two following biobricks:</p> | Using these two systems (dCas9 recognition and FRB/FKBP12 dimerization) we design our new tool based on the two following biobricks:</p> | ||
− | + | ||
[[Image:Image2design.jpg|frameless|center|upright=2.5|alt=dCas9 mecanism]] | [[Image:Image2design.jpg|frameless|center|upright=2.5|alt=dCas9 mecanism]] | ||
− | + | ||
<p style="font-size:11pt">These two biobricks will be assembled in pSB1C3 plasmid give us our get DNA closer tool which will function as bellow:</p> | <p style="font-size:11pt">These two biobricks will be assembled in pSB1C3 plasmid give us our get DNA closer tool which will function as bellow:</p> | ||
− | + | ||
[[Image:Image3design.jpg|frameless|center|upright=2|alt=dCas9 mecanism]] | [[Image:Image3design.jpg|frameless|center|upright=2|alt=dCas9 mecanism]] | ||
− | |||
=<span style="color: MediumVioletRed;">Visualization tool construction</span>= | =<span style="color: MediumVioletRed;">Visualization tool construction</span>= | ||
Line 30: | Line 29: | ||
It will be fulfilling with a new and unreleased in the iGEM competition tripartite slip-GFP. <br><br> | It will be fulfilling with a new and unreleased in the iGEM competition tripartite slip-GFP. <br><br> | ||
The tripartit split-GFP is composed of two twenty amino-acids long GFP tags (GFP10 and GFP11) and a third complementary subsection (GFP1-9). The tags will be fused to the two dCas9 previously quoted. A functional GFP will be achieved when the tools would be close enought to allow the three slip-GFP parts reunion and the fluorescence emission. This fluorescence system avoids poor folding and/or self-assembly background fluorescence. With this system, only two sgRNAs associate with their dCas9s fused to their specific GFP tags will be necessary instead of nearly 30 with mundane GFP due to background fluorescence.<br><br> | The tripartit split-GFP is composed of two twenty amino-acids long GFP tags (GFP10 and GFP11) and a third complementary subsection (GFP1-9). The tags will be fused to the two dCas9 previously quoted. A functional GFP will be achieved when the tools would be close enought to allow the three slip-GFP parts reunion and the fluorescence emission. This fluorescence system avoids poor folding and/or self-assembly background fluorescence. With this system, only two sgRNAs associate with their dCas9s fused to their specific GFP tags will be necessary instead of nearly 30 with mundane GFP due to background fluorescence.<br><br> | ||
− | The team has designed three biobricks to achieve this part of the project: | + | The team has designed three biobricks to achieve this part of the project:</p> |
<br><br> | <br><br> | ||
* '''Biobrick n°3 :''' ''N.meningitidis'' fused to GFP-10 expressed by a constitutive promoter, a RBS and a double terminator | * '''Biobrick n°3 :''' ''N.meningitidis'' fused to GFP-10 expressed by a constitutive promoter, a RBS and a double terminator | ||
Line 36: | Line 35: | ||
* '''Biobrick n°5 :''' The third part of the GFP 1-9 expressed by a constitutive promoter, a RBS and a double terminator | * '''Biobrick n°5 :''' The third part of the GFP 1-9 expressed by a constitutive promoter, a RBS and a double terminator | ||
<br> | <br> | ||
− | The biobricks were inserted into pSB1C3 using the iGEM process : restriction sites EcoRI and PstI.</p> | + | <p style="font-size:11pt">The biobricks were inserted into pSB1C3 using the iGEM process : restriction sites EcoRI and PstI.</p> |
− | + | ||
[[File:T--Paris_Saclay--visualization_biobricks.jpeg|frameless|center|upright=2.5|]] | [[File:T--Paris_Saclay--visualization_biobricks.jpeg|frameless|center|upright=2.5|]] | ||
− | + | ||
<p style="font-size:11pt">Then, the team has considered to establish a composite biobrick composed of the three biobricks in the same pSB1C3 plasmid. This plasmid would have been build using the iGEM restriction site technique.</p> | <p style="font-size:11pt">Then, the team has considered to establish a composite biobrick composed of the three biobricks in the same pSB1C3 plasmid. This plasmid would have been build using the iGEM restriction site technique.</p> | ||
<br> | <br> |
Revision as of 11:49, 7 October 2016